Head-to-head · Cost-Efficiency Index
Eden vs Lean Meds
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Eden
People who will trade a higher sticker price for verified nationwide access and stronger clinical oversight.
Visit EdenLean Meds
Cost-first shoppers who want a genuinely flat all-dose price and named pharmacies, and who will read the $49 headline as the annual plan it is.
Visit Lean MedsThe verdict
Eden takes it, leading the Cost-Efficiency Index 86 to 84. You pay a premium per month, but you buy back certainty: all-50 access and high-disclosure clinical oversight that hold their value. Lean Meds still earns a B — Cost-first shoppers who want a genuinely flat all-dose price and named pharmacies, and who will read the $49 headline as the annual plan it is.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Eden.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Eden | Lean Meds |
|---|---|---|
| Cost-Efficiency Index | 86/100 | 84/100 |
| Semaglutide / mo | $239/mo | $79/mo month-to-month, flat at every dose (the advertised $49 is the 12-month plan) |
| Tirzepatide / mo | $349/mo | $109/mo month-to-month, flat at every dose (the advertised $95 is the 12-month plan) |
| Semaglutide / yr (modeled) | $2,868 | $948 |
| Tirzepatide / yr (modeled) | $4,188 | $1,308 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #15 | #21 |
Eden
86/100Where the value is
- High transparency — clear supply-chain and clinician disclosure lowers hidden-cost risk
- Nationwide availability with both molecules disclosed
- Strong clinical oversight adds value beyond the raw price
The tradeoffs
- Premium per-month cost drags its normalized value score
- Compounded only — no brand-name access
Regulatory note: the FDA issued a warning letter to Eden Health International Inc. dba Eden in June 2026. We still list and link to Eden; you should know the letter is on the public record before you decide.
Lean Meds
84/100Where the value is
- A flat rate at every dose on both molecules, stated as such, so the price does not climb as a provider titrates
- Names all four pharmacies in its network with addresses, phone numbers and websites, and states the 503A designation in the footer of every page
- The full four-rung ladder for each molecule is printed on one page, so a reader can see what a commitment actually saves
The tradeoffs
- The homepage sells "Starting at $49/mo — same price every month, first order and every order after"; $49 is the twelve-month semaglutide plan and the month-to-month rate is $79
- A homepage chip reads "No auto rebill" while the terms say the payment method is automatically charged at recurring intervals until you cancel
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.